Healthcare has proved to be an important sector to have exposure to over the past few years, because of the explosion of new medicines hitting the market and the positive impact of Obamacare on the earnings of some insurance companies and information technology companies alike. The Health Care Select Sector SPDR (NYSEMKT: XLV), for instance, has crushed the broader markets since 2010:
An unwelcome mixture of rising debt levels at a time of potentially shrinking operating margins -- driven by the drug-pricing debate -- has the market spooked, so to speak, leading to these compressed forward P/E ratios. While the market's fear may turn out to be warranted, there are still some compelling buys in pharma that shouldn't be ignored. In fact, I think Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) should produce market-beating returns in 2016, making it a great pick-up for the new year.
Source: Motley Fool
Related Articles:
- Dividend Growth Stocks Are My Conviction
- All Investing Involves Risk
- 7 Dividend Stocks With Room To Increase Their Payout
- High-Quality, Low-Risk Dividend Stocks
- 10 Stocks Building Wealth Through Higher Dividends
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
If you’ve been following this column, you’d know that monthly dividend stocks tend to come from two main types of businesses: real estate an...
-
Late last year, Wall Street had a bit of a panic attack when Fed chairman Jerome Powell suggested this tightening was on autopilot. While th...
-
Are you sick and tired of low interest rates? Certificates of deposit pay next to nothing. Bonds yield only three or four percent a year. Su...
-
These three picks are all up more than 10% so far in 2019. The three themes are LNG, specialized healthcare, and small banks. The yields ran...
-
This company makes a compelling value proposition based on valuation, risk/reward, yield, and upside potential. I added this hotel REIT las...
-
This company makes a compelling value proposition on the dip for DGI investors. The REIT has strong portfolio stats and a conservative AFFO-...
-
Stocks with high dividend yields can be great, but if a stock has a high dividend yield and also has lots of long-term growth potential and ...
-
At its opening price of $101 per share on Jan. 7, MSFT stock had a market cap of $782 billion, which made it the most valuable company in th...
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
Dividend growth or dividend yield. Which should investors prefer? I'm firmly in the "growth" camp since I'm still a few de...
0 comments
Post a Comment
Post a Comment